T-cell infiltrate after monoclonal anti-CD20 antibody therapy.

被引：0
|
作者：
Vincent-Salomon, A [1 ]
Mathiot, C [1 ]
Macintyre, E [1 ]
Girre, V [1 ]
Fourquet, A [1 ]
Mercier, C [1 ]
Fréneaux, P [1 ]
Dumont, J [1 ]
Decaudin, D [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4353
引用
收藏
页码：256B / 256B
页数：1
相关论文
共 50 条
  • [31] Compliance of protocol-driven hepatitis B serological screening in patients receiving anti-CD20 monoclonal antibody therapy.
    Schluenz, Lauren
    Jeffers, Kate
    Kalis, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [32] Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody
    Matteucci, P
    Magni, M
    Di Nicola, M
    Carlo-Stella, C
    Uberti, C
    Gianni, AM
    BLOOD, 2002, 100 (03) : 1104 - 1105
  • [33] Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    Bhatia, A
    Ell, PJ
    Edwards, JCW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1099 - 1100
  • [34] Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    Hagberg, H
    Lundholm, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 609 - 611
  • [35] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [36] B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism
    Ueki, I.
    Abiru, N.
    Kobayashi, M.
    Nakahara, M.
    Ichikawa, T.
    Eguchi, K.
    Nagayama, Y.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 163 (03): : 309 - 317
  • [37] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [38] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [39] B-cell depletion in patients with multiple myeloma with the anti-CD20 monoclonal antibody rituximab after high dose therapy
    Witzens, M
    Gemmel, C
    Moos, M
    Goldschmidt, H
    Ho, AD
    BONE MARROW TRANSPLANTATION, 1999, 23 : S141 - S141
  • [40] Anti-CD20 Monoclonal Antibody Therapy and Minimal Residual Disease Status of T-Cell/Histiocyte-Rich Large B Cell Non-Hodgkin Lymphoma
    Valera, Elvis Terci
    Queiroz, Rosane Gomes
    Brassesco, Maria Sol
    Scrideli, Carlos Alberto
    Neves, Fabia
    Tone, Luiz Gonzaga
    PEDIATRIC BLOOD & CANCER, 2011, 57 (02) : 348 - 349
12345